经济发展新格局下建设生物制造产业科技创新平台的路径与对策——基于北欧两国经验的比较
DOI:
CSTR:
作者:
作者单位:

1.南京工业大学生物与制药工程学院;2.南京工业大学 生物与制药工程学院

作者简介:

通讯作者:

中图分类号:

F402.3;Q819;G301

基金项目:

江苏省学位与研究生教育教学改革课题“面向江苏省生物医药产业链发展的校企所联合培养研究生平台建设与运行机制研究”(JGKT23_C028)


The Path and Countermeasures of Building a Scientific and Technological Innovation Platform for the Bio-manufacturing Industry under the New Pattern of Development: Comparison Based on the Experience of Two Nordic Countries
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    生物制造技术是迈向生物经济时代与“双碳”目标背景下实现工业制造高质量发展的重要方法与手段,也是全球各国竞相发展的战略性新兴产业。高水平科技创新平台建设是推动生物制造高质量发展的重要路径,为有效借鉴国外先进经验,比较北欧国家瑞典和丹麦与中国生物制造产业发展异同点的基础上,系统分析两国围绕建设生物制造产业科创平台应对资源与环境可持续发展压力的创新举措。基于瑞典重点发展以生物质能为代表的森林生物技术中心、Testa中心和丹麦诺和诺德基金会建立生物可持续研究中心来发展生物制造产业技术的成功经验,提出加大政府引导、扩大资金投入、促进企业主体地位、探索创新运行管理模式、集聚国际优势团队打造成果转化长效机制等建设生物制造产业科创平台的路径与对策,以促进我国从生物制造大国向强国转变。

    Abstract:

    Bio-manufacturing technology is one of the important pathways to achieve high-quality development of industrial manufacturing under the current "double carbon" goal and the sustainable development of environmental resources. It is also a strategic emerging industry that all the countries around the world are competing to develop. The construction of a high-level scientific and technological innovation platform is an important path to promote the high-quality development of biological manufacturing. In order to effectively learn from foreign advanced experience, based on the comparison of the similarities and differences between the Nodic countries (Sweden and Denmark) and China's bio-manufacturing industry development, this paper systematically analyzes the measures taken by the two Nordic countries to deal with the pressure of resources and environment around the construction of bio-manufacturing industry science and technology innovation platform. Based on the successful experience of bio-manufacturing industry represented by Berzelii Centre for Forest Biotechnology, Testa Centre, and Novo Nordisk Foundation Center for Biosustainability, this paper puts forward the path and countermeasures of building a science and technology innovation platform for the bio-manufacturing industry, such as increasing government guidance, expanding capital investment, promoting the dominant position of enterprises, exploring innovative operation and management models, and gathering international advantageous teams to create a long-term mechanism for the transformation of achievements, so as to promote China 's transformation from a big bio-manufacturing country to a powerful country.

    参考文献
    相似文献
    引证文献
引用本文

王浩绮,周小力,刘兆星,纪晓俊.经济发展新格局下建设生物制造产业科技创新平台的路径与对策——基于北欧两国经验的比较[J].,2024,44(9).

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2023-10-23
  • 最后修改日期:2024-05-17
  • 录用日期:2024-01-04
  • 在线发布日期: 2025-03-19
  • 出版日期:
文章二维码

联系电话:020-37635126(一、三、五)/83568469(二、四)(查稿)、37674300/82648174(编校)、37635521/82640284(财务)、83549092(传真)

联系地址:广东省广州市先烈中路100号大院60栋3楼302室(510070) 广东省广州市越秀区东风西路207-213星河亚洲金融中心A座8楼(510033)

邮箱:kjgl83568469@126.com kjgl@chinajournal.net.cn

科技管理研究 ® 2025 版权所有
技术支持:北京勤云科技发展有限公司
关闭
关闭